CAS: 1078166-57-0 - 1-(4-Fluorobenzoyl)-3-[[(6-methoxy-2-naphthalenyl)oxy]methyl]-3-azetidinecarboxylic acid
- Synonyms:
- Pf 04418948
- 1-(4-Fluorobenzoyl)-3-[(6-Methoxynaphthalen-2-Yl)Oxymethyl]Azetidine-3-Carboxylic Acid
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PF 04418948 REF: IN-DA008TMWCAS: 1078166-57-0 | % | To inquire | Tue 10 Dec 24 |
 | PF-04418948 REF: TM-T3306CAS: 1078166-57-0 | 97.61% - 99.45% | 47.00 €~348.00 € | Mon 16 Dec 24 |
 | PF 04418948 REF: TR-P218295CAS: 1078166-57-0 | - - - | 1,056.00 € | Tue 21 Jan 25 |
 | PF-04418948 REF: 3D-DTB16657CAS: 1078166-57-0 | Min. 95% | To inquire | Tue 21 Jan 25 |
Ref: IN-DA008TMW
| 5mg | 62.00 € | ||
| 10mg | 100.00 € | ||
| 25mg | 163.00 € | ||
| 50mg | 196.00 € | ||
| 100mg | 313.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
PF-04418948
CAS:1078166-57-0
PF-04418948 is a potent EP2 receptor antagonist. Displays over 2000-fold selectivity for EP2 receptors over …
Formula:
C23H20FNO5
Purity:
97.61% - 99.45%
Color and Shape:
Solid
Molecular weight:
409.41
Ref: TM-T3306
| 2mg | 47.00 € | ||
| 5mg | 68.00 € | ||
| 10mg | 87.00 € | ||
| 25mg | 183.00 € | ||
| 50mg | 315.00 € | ||
| 100mg | 348.00 € | ||
| 1mL*10mM (DMSO) | 75.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
PF 04418948
Controlled ProductCAS:1078166-57-0
Applications PF 04418948 acts as a novel, potent and selective prostoglandin EP2 receptor antagonist. References …
Formula:
C23H20FNO5
Color and Shape:
Neat
Molecular weight:
409.407
Ref: TR-P218295
| 50mg | 1,056.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
PF-04418948
CAS:1078166-57-0
PF-04418948 is a potent and selective antagonist of the camp receptor. It inhibits the binding …
Formula:
C23H20FNO5
Purity:
Min. 95%
Molecular weight:
409.41 g/mol
Ref: 3D-DTB16657
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
